Trial Profile
A retrospective study of clarithromycin based triple therapy for Helicobacter pylori infections and duodenal ulcers
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs Amoxicillin and clarithromycin and omeprazole (Primary)
- Indications Duodenal ulcer; Helicobacter pylori infections
- Focus Therapeutic Use
- 02 Apr 2018 New trial record
- 26 Mar 2018 According to a Cumberland Pharmacuticals media release, results from this study were published in the Journal, Infection and Drug Resistance.